6 April 2024 false No description of principal activity Taxfiler 2024.6 12747694 business:PrivateLimitedCompanyLtd 2024-04-06 2025-04-05 12747694 2024-04-05 12747694 2024-04-06 2025-04-05 12747694 business:AuditExempt-NoAccountantsReport 2024-04-06 2025-04-05 12747694 business:FilletedAccounts 2024-04-06 2025-04-05 12747694 2025-04-05 12747694 2024-04-05 12747694 core:WithinOneYear 2025-04-05 12747694 core:WithinOneYear 2024-04-05 12747694 core:ShareCapital core:PreviouslyStatedAmount 2025-04-05 12747694 core:ShareCapital core:PreviouslyStatedAmount 2024-04-05 12747694 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-04-05 12747694 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-04-05 12747694 core:PreviouslyStatedAmount 2025-04-05 12747694 core:PreviouslyStatedAmount 2024-04-05 12747694 business:SmallEntities 2024-04-06 2025-04-05 12747694 business:Director1 2024-04-06 2025-04-05 12747694 countries:EnglandWales 2024-04-06 2025-04-05 12747694 business:RegisteredOffice 2024-04-06 2025-04-05 12747694 core:IntangibleAssetsOtherThanGoodwill 2024-04-05 12747694 core:IntangibleAssetsOtherThanGoodwill 2025-04-05 12747694 core:IntangibleAssetsOtherThanGoodwill 2024-04-06 2025-04-05 12747694 core:PlantMachinery 2024-04-05 12747694 core:ComputerEquipment 2024-04-05 12747694 core:PlantMachinery 2025-04-05 12747694 core:ComputerEquipment 2025-04-05 12747694 core:PlantMachinery 2024-04-06 2025-04-05 12747694 core:ComputerEquipment 2024-04-06 2025-04-05 12747694 2023-04-06 2024-04-05 iso4217:GBP xbrli:pure
Company Registration No. 12747694 (England and Wales)
Biotech Research Laboratories Limited Unaudited accounts for the year ended 5 April 2025
Biotech Research Laboratories Limited Statement of financial position as at 5 April 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
5,938
7,423
Tangible assets
5
120,528
179,895
126,466
187,318
Current assets
Debtors
6
16,568
42,716
Cash at bank and in hand
1,116
11,098
17,684
53,814
Creditors: amounts falling due within one year
7
(371,813)
(368,143)
Net current liabilities
(354,129)
(314,329)
Net liabilities
(227,663)
(127,011)
Capital and reserves
Called up share capital
100
100
Profit and loss account
(227,763)
(127,111)
Shareholders' funds
(227,663)
(127,011)
For the year ending 5 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 14 January 2026 and were signed on its behalf by
Thomas Meany Director Company Registration No. 12747694
- 2 -
Biotech Research Laboratories Limited Notes to the Accounts for the year ended 5 April 2025
1
Statutory information
Biotech Research Laboratories Limited is a private company, limited by shares, registered in England and Wales, registration number 12747694. The registered office is Peachey & Co Llp, 95 Aldwych, London, WC2B 4JF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other
£
Cost
At 6 April 2024
9,279
At 5 April 2025
9,279
Amortisation
At 6 April 2024
1,856
Charge for the year
1,485
At 5 April 2025
3,341
Net book value
At 5 April 2025
5,938
At 5 April 2024
7,423
- 3 -
Biotech Research Laboratories Limited Notes to the Accounts for the year ended 5 April 2025
5
Tangible fixed assets
Plant & machinery
Computer equipment
Total
£
£
£
Cost or valuation
At cost
At cost
At 6 April 2024
258,567
9,935
268,502
At 5 April 2025
258,567
9,935
268,502
Depreciation
At 6 April 2024
85,328
3,279
88,607
Charge for the year
57,170
2,197
59,367
At 5 April 2025
142,498
5,476
147,974
Net book value
At 5 April 2025
116,069
4,459
120,528
At 5 April 2024
173,239
6,656
179,895
6
Debtors
2025
2024
£
£
Amounts falling due within one year
Accrued income and prepayments
16,568
42,716
7
Creditors: amounts falling due within one year
2025
2024
£
£
VAT
(1,179)
1,284
Trade creditors
8,965
7,950
Other creditors
294
294
Loans from directors
363,314
358,162
Accruals
419
453
371,813
368,143
8
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 4 -